Howard Capital Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
1,480
+100
+7% +$102K 0.11% 46
2026
Q1
$1.27M Sell
1,380
-280
-17% -$284K 0.08% 51
2025
Q4
$1.78M Buy
1,660
+892
+116% +$853K 0.11% 48
2025
Q3
$586K Buy
768
+150
+24% +$112K 0.04% 80
2025
Q2
$482K Hold
618
0.03% 83
2025
Q1
$510K Hold
618
0.04% 79
2024
Q4
$477K Hold
618
0.03% 85
2024
Q3
$548K Sell
618
-38
-6% -$34.2K 0.04% 82
2024
Q2
$594K Sell
656
-75
-10% -$60K 0.04% 75
2024
Q1
$569K Hold
731
0.04% 78
2023
Q4
$426K Sell
731
-50
-6% -$29.2K 0.04% 76
2023
Q3
$419K Hold
781
0.04% 72
2023
Q2
$366K Sell
781
-363
-32% -$152K 0.03% 79
2023
Q1
$393K Buy
1,144
+196
+21% +$66.1K 0.04% 76
2022
Q4
$347K Hold
948
0.04% 77
2022
Q3
$307K Hold
948
0.04% 75
2022
Q2
$307K Hold
948
0.04% 78
2022
Q1
$271K Hold
948
0.02% 89
2021
Q4
$262K Buy
948
+46
+5% +$11.7K 0.02% 95
2021
Q3
$208K Buy
+902
New +$223K 0.02% 101

Other funds holding LLY

Howard Capital Management Group's LLY Position: Q2 2026 in Review

Howard Capital Management Group increased its Eli Lilly (LLY) stake by 7.2% in Q2 2026, buying an estimated $102K and bringing the position to 1,480 shares worth $1.78M. The position accounts for 0.11% of the portfolio, ranked #46.

Howard Capital Management Group first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.78M in Q4 2025. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Howard Capital Management Group held 1,480 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • Howard Capital Management Group bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.11% of Howard Capital Management Group's portfolio in Q2 2026, its #46 holding.
  • Howard Capital Management Group first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
  • Howard Capital Management Group's Eli Lilly position peaked at $1.78M in Q4 2025.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.